These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 2351489

  • 1. In vitro therapeutic targeting of neuroblastomas using 125I-labelled meta-iodobenzylguanidine.
    Guerreau D, Thedrez P, Fritsch P, Saccavini JC, Metivier H, Nolibe D, Masse R, Coornaert S, Chatal JF.
    Int J Cancer; 1990 Jun 15; 45(6):1164-8. PubMed ID: 2351489
    [Abstract] [Full Text] [Related]

  • 2. Cytotoxic effects of m-[131I]- and m-[125I]iodobenzylguanidine on the human neuroblastoma cell lines SK-N-SH and SK-N-LO.
    Bruchelt G, Girgert R, Buck J, Wolburg H, Niethammer D, Treuner J.
    Cancer Res; 1988 Jun 01; 48(11):2993-7. PubMed ID: 3365688
    [Abstract] [Full Text] [Related]

  • 3. Active uptake and extravesicular storage of m-iodobenzylguanidine in human neuroblastoma SK-N-SH cells.
    Smets LA, Loesberg C, Janssen M, Metwally EA, Huiskamp R.
    Cancer Res; 1989 Jun 01; 49(11):2941-4. PubMed ID: 2720653
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics and intracellular distribution of the tumor-targeted radiopharmaceutical m-iodo-benzylguanidine in SK-N-SH neuroblastoma and PC-12 pheochromocytoma cells.
    Smets LA, Janssen M, Rutgers M, Ritzen K, Buttenhuis C.
    Int J Cancer; 1991 Jun 19; 48(4):609-15. PubMed ID: 2045205
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of adrenergic receptor ligands on metaiodobenzylguanidine uptake and storage in neuroblastoma cells.
    Babich JW, Graham W, Fischman AJ.
    Eur J Nucl Med; 1997 May 19; 24(5):538-43. PubMed ID: 9142735
    [Abstract] [Full Text] [Related]

  • 7. Distribution of m-IBG in nude mice bearing LAN-5 neuroblastoma xenografts and in vitro cell culture.
    Van der Wall H, Durbidge M, White L, Taylor D, Murray IP.
    In Vivo; 1991 May 19; 5(2):123-6. PubMed ID: 1768781
    [Abstract] [Full Text] [Related]

  • 8. Specific uptake of m-[125I]iodobenzylguanidine in the human neuroblastoma cell line SK-N-SH.
    Buck J, Bruchelt G, Girgert R, Treuner J, Niethammer D.
    Cancer Res; 1985 Dec 19; 45(12 Pt 1):6366-70. PubMed ID: 3864530
    [Abstract] [Full Text] [Related]

  • 9. No-carrier-added iodine-131-FIBG: evaluation of an MIBG analog.
    Vaidyanathan G, Zhao XG, Strickland DK, Zalutsky MR.
    J Nucl Med; 1997 Feb 19; 38(2):330-4. PubMed ID: 9025764
    [Abstract] [Full Text] [Related]

  • 10. A 4-methyl-substituted meta-iodobenzylguanidine analogue with prolonged retention in human neuroblastoma cells.
    Vaidyanathan G, Welsh PC, Vitorello KC, Snyder S, Friedman HS, Zalutsky MR.
    Eur J Nucl Med Mol Imaging; 2004 Oct 19; 31(10):1362-70. PubMed ID: 15205923
    [Abstract] [Full Text] [Related]

  • 11. Catabolism of 4-fluoro-3-iodobenzylguanidine and meta-iodobenzylguanidine by SK-N-SH neuroblastoma cells.
    Vaidyanathan G, Affleck DJ, Alston KL, Welsh P, Zalutsky MR.
    Nucl Med Commun; 2004 Sep 19; 25(9):947-55. PubMed ID: 15319601
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics and efficacy of 131I-meta-iodobenzylguanidine in two neuroblastoma xenografts.
    Gaze MN, Hamilton TG, Mairs RJ.
    Br J Radiol; 1994 Jun 19; 67(798):573-8. PubMed ID: 8032811
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic effect of m-[131I]- and m-[125I]iodobenzylguanidine on neuroblastoma multicellular tumor spheroids of different sizes.
    Weber W, Weber J, Senekowitsch-Schmidtke R.
    Cancer Res; 1996 Dec 01; 56(23):5428-34. PubMed ID: 8968097
    [Abstract] [Full Text] [Related]

  • 14. 3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells.
    Vaidyanathan G, Zhao XG, Larsen RH, Zalutsky MR.
    Br J Cancer; 1997 Dec 01; 76(2):226-33. PubMed ID: 9231923
    [Abstract] [Full Text] [Related]

  • 15. In vitro pharmacology of metaiodobenzylguanidine uptake, storage and release in human neuroblastoma cells.
    Montaldo PG, Carbone R, Lanciotti M, Ponzoni M, Cornaglia-Ferraris P.
    J Nucl Biol Med (1991); 1991 Dec 01; 35(4):195-8. PubMed ID: 1823817
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Increase of metaiodobenzylguanidine uptake and intracellular half-life during differentiation of human neuroblastoma cells.
    Montaldo PG, Raffaghello L, Guarnaccia F, Pistoia V, Garaventa A, Ponzoni M.
    Int J Cancer; 1996 Jul 03; 67(1):95-100. PubMed ID: 8690531
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Targeting of meta-iodobenzylguanidine to SK-N-SH human neuroblastoma xenografts: tissue distribution, metabolism and therapeutic efficacy.
    Rutgers M, Buitenhuis CK, Hoefnagel CA, Voûte PA, Smets LA.
    Int J Cancer; 2000 Aug 01; 87(3):412-22. PubMed ID: 10897048
    [Abstract] [Full Text] [Related]

  • 20. Accumulation of m-iodobenzylguanidine by neuroblastoma cells results from independent uptake and storage mechanisms.
    Montaldo PG, Lanciotti M, Casalaro A, Cornaglia-Ferraris P, Ponzoni M.
    Cancer Res; 1991 Aug 15; 51(16):4342-6. PubMed ID: 1868458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.